Boston, Massachusetts
United States
8
2024-04-11
8
2026-04-28
These are the the leading inventors for applications assigned to Constellation Pharmaceuticals, Inc.:
Constellation Pharmaceuticals, Inc. based in Boston, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF
#2 | 2023-02-23 ✅ Patent 12,070,464 granted on 2024-08-27Methods of treating myeloproliferative disorders
#3 | 2022-08-11 ✅ Patent 12,516,040 granted on 2026-01-06CRYSTALLINE FORMS OF 7-CHLORO-2-(4-(3-METHOXYAZETIDIN-1-YL)CYCLOHEXYL)-2,4-DIMETHYL-N-((6-METHYL-4-(METHYLTHIO)-2-OXO-1,2-DIHYDROPYRIDIN-3-YL)METHYL)BENZO[D][1,3]DIOXOLE-5-CARBOXAMIDE
#4 | 2022-03-17 ✅ Patent 11,547,695 granted on 2023-01-10LSD1 inhibitors and medical uses thereof
#5 | 2022-01-20 ✅ Patent 12,172,990 granted on 2024-12-24Modulators of TREX1
#6 | 2021-07-29 ✅ Patent 11,459,315 granted on 2022-10-04Modulators of methyl modifying enzymes, compositions and uses thereof
#7 | 2021-07-08 ✅ Patent 11,919,912 granted on 2024-03-05Modulators of methyl modifying enzymes, compositions and uses thereof
#8 | 2021-03-04 ✅ Patent 11,414,384 granted on 2022-08-16P300/CBP hat inhibitors
Also check out Constellation Pharmaceuticals, Inc.'s (Boston, United States) applicant profile with 15 patent applications submitted.
354732 ⎘